Daniel Gotthardt - CompuGroup Medical Member of the Supervisory Board
| CMPUY Stock | USD 32.38 0.00 0.00% |
Executive
Prof. Dr. Daniel Gotthardt was Deputy Chairman of the Supervisory Board of CompuGroup Medical Aktiengesellschaft since May 14 2014. Prior to that he was Member of the Supervisory Board of the Company from 2003. He serves as Member of the Audit Committee at the Company. He is Doctor at the University Clinic Heidelberg since 2014.
| Tenure | 10 years |
| Professional Marks | Ph.D |
| Phone | 49 261 8000 0 |
| Web | https://www.cgm.com |
CompuGroup Medical Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1153 %, meaning that it generated $0.1153 on every $100 dollars invested by stockholders. CompuGroup Medical's management efficiency ratios could be used to measure how well CompuGroup Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kristine Diamond | Veeva Systems Class | 56 | |
| Jacques Mourrain | Veeva Systems Class | N/A | |
| Frank Esq | GE HealthCare Technologies | 59 | |
| Rana Strellis | GE HealthCare Technologies | N/A | |
| Brad Bennion | HealthEquity | N/A | |
| Jahid Khandaker | GE HealthCare Technologies | N/A | |
| Kenneth Stacherski | GE HealthCare Technologies | 52 | |
| Steve Lindsay | HealthEquity | N/A | |
| George Newcomb | GE HealthCare Technologies | 57 | |
| Richard Putnam | HealthEquity | N/A | |
| Paul Harrington | Solventum Corp | N/A | |
| Tia Padia | HealthEquity | N/A | |
| MS MD | GE HealthCare Technologies | 52 | |
| Nitsa Zuppas | Veeva Systems Class | 47 | |
| Betty Larson | GE HealthCare Technologies | 48 | |
| Amy Landucci | Solventum Corp | N/A | |
| Carolynne Borders | GE HealthCare Technologies | N/A | |
| Mary Wilcox | Solventum Corp | N/A | |
| Michele OConnor | Veeva Systems Class | 47 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 |
CompuGroup Medical Leadership Team
Elected by the shareholders, the CompuGroup Medical's board of directors comprises two types of representatives: CompuGroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CompuGroup. The board's role is to monitor CompuGroup Medical's management team and ensure that shareholders' interests are well served. CompuGroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CompuGroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angela Teufer, Connectivity DACH | ||
| Rene Obermann, Member of the Supervisory Board | ||
| Lothar Wild, Member of the Supervisory Board | ||
| Uwe Eibich, Executive VP of Central Europe and Member of Management Board | ||
| Klaus Esser, Deputy Chairman of the Supervisory Board | ||
| Emanuele Mugnani, MD Board | ||
| Ulrike Flach, Member of the Supervisory Board | ||
| Christian Teig, CFO, Fin. Director and Member of Management Board | ||
| Helge Wei, VP Connectivity | ||
| Hannes Reichl, MD Board | ||
| Alexander Weimer, Head Communications | ||
| Daniel Gotthardt, Member of the Supervisory Board | ||
| Michael Franz, Co Communication | ||
| Oliver Bruzek, Chief Affairs | ||
| Frank Gotthardt, Chairman of Management Board and CEO | ||
| MBA LLM, MD CFO | ||
| Claudia Thom, Co Relations | ||
| Eckart Pech, MD Board | ||
| Frank Brecher, Chief Process Officer and Member of Management Board | ||
| Karl Gruener, Member of the Supervisory Board |
CompuGroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CompuGroup Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 25.48 X | |||
| Price To Book | 2.94 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CompuGroup Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CompuGroup Medical's short interest history, or implied volatility extrapolated from CompuGroup Medical options trading.
Pair Trading with CompuGroup Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CompuGroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CompuGroup Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with CompuGroup OTC Stock
| 0.84 | MTHRF | M3 Inc | PairCorr |
Moving against CompuGroup OTC Stock
| 0.91 | GEHC | GE HealthCare Techno Financial Report 23rd of April 2024 | PairCorr |
| 0.89 | TRGP | Targa Resources Financial Report 2nd of May 2024 | PairCorr |
| 0.89 | ENTG | Entegris Financial Report 9th of May 2024 | PairCorr |
| 0.84 | GE | GE Aerospace Earnings Call This Week | PairCorr |
| 0.8 | CRBP | Corbus Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to CompuGroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CompuGroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CompuGroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CompuGroup Medical SE to buy it.
The correlation of CompuGroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CompuGroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CompuGroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CompuGroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical SE. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for CompuGroup OTC Stock analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |